Sat, Dec 20, 2014, 3:51 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Ironwood Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • aany23 aany23 Dec 11, 2012 5:02 PM Flag

    IRWD owns a key patent on plecanatide

    The LOI is binding and the broad terms have been outlined and already agreed upon (i.e. royalty limits, global license, etc). Overstating things you don't know about is pathetic. You have no direct line of sight regarding the remaining negotiating points, and logic dictates that both sides had proper legal council and appropriately covered their liabilities.

    Additionally, Ironwood only holds a flimsy method of use patent, not a product patent. And since they have failed to mobilize development activities towards commercialization of a product as defined under the Hatch-Waxman act, Synergy could have easily challenged and won (with high probability) a legal ruling without entering any agreement with Ironwood.

    Bottom line: This agreement clears the way for SGYP to either partner or sell once they've cleared the clinical hurdle in early January.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You clearly haven't been involved in licensing negotiations. There is a pretty large distance between LOI and executed license agreement. Synergy put out this press release not Ironwood. You have to ask, why would Ironwood accommodate a competitor? Spare me Hatch-Waxman, as companies sit on strategic IP all the time...

      Synergy will not at all like the final terms they will be offered. At that point, they can swallow or infringe and litigate. IRWD is in the drivers seat.

      • 1 Reply to jrus2010
      • keep making assumptions, but you clearly don't understand the nuances of a method-of-use patent in the context of hatch-waxman and the limited protection it provides in this case. You really should do your homework on this before making grand claims, but then again it only is a Yahoo! MB so no harm done.

        either way good luck, this class of drug is going to be huge. IRWD should be very well and SGYP should see a nice financial windfall next year in either a lucrative partnership or an M&A deal

14.79-0.27(-1.79%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
3M Company
NYSEFri, Dec 19, 2014 4:04 PM EST
ImmunoGen, Inc.
NASDAQFri, Dec 19, 2014 4:00 PM EST
Southwestern Energy Co.
NYSEFri, Dec 19, 2014 4:05 PM EST